Success of immune checkpoint blockade therapies - mechanisms and implications for hepatology

Bertram Bengsch1,2, Robert Thimme1

  • 1Department of Medicine II, Gastroenterology, Hepatology, Endocrinology, and Infectious Diseases, University Medical Center Freiburg, Faculty of Medicine, Germany.

Zeitschrift Fur Gastroenterologie
|January 15, 2019
PubMed

Insights

Immune checkpoint blockade therapy is revolutionizing cancer treatment, showing promise in liver cancer by boosting anti-tumor immune responses. However, understanding its complex immunobiology and managing immune-related side effects remains crucial for hepatologists.

Area of Science:

  • Oncology
  • Immunology
  • Hepatology

Background:

  • Immune checkpoint blockade therapies are transforming oncology, yielding durable responses in advanced cancers.
  • These therapies reinvigorate adaptive antitumor immunity by releasing negative feedback pathways.
  • Effectiveness is highest in patients with pre-existing T cell responses and high neoantigen tumors.

Purpose of the Study:

  • To review the immunological mechanisms of checkpoint blockade therapies.
  • To discuss the implications of these therapies for liver cancer treatment.
  • To highlight challenges in managing immune-related adverse events in hepatology.

Main Methods:

  • Literature review of current checkpoint blockade therapies.
  • Analysis of immunological mechanisms and clinical trial data in liver cancer.
  • Discussion of clinical challenges and management strategies for hepatologists.

Main Results:

  • Checkpoint blockade shows promise in liver cancer clinical trials.
  • Understanding the underlying immunobiology is essential for optimizing treatment.
  • Immune-related adverse events, such as hepatitis, present new clinical challenges.

Conclusions:

  • Checkpoint blockade offers novel therapeutic options for challenging liver cancers.
  • Further research into immunobiology is needed to improve efficacy and safety.
  • Hepatologists require specific knowledge to manage immune-related side effects effectively.

Related Concept Videos

Ecological Succession02:17

Ecological Succession

Ecological succession is influenced by the processes of facilitation, inhibition, and toleration. Facilitation occurs when early successional species create more favorable ecological conditions for subsequent species, such as enhanced nutrient, water, or light availability. In contrast, inhibition happens when early successional species create unfavorable ecological conditions for potential successive species, such as limiting resource availability. In some cases, later successional species...
21.5K
Neuromuscular Junction And Blockade01:29

Neuromuscular Junction And Blockade

The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
5.0K
The Spindle Assembly Checkpoint02:19

The Spindle Assembly Checkpoint

The spindle assembly checkpoint is a molecular surveillance mechanism ensuring the fidelity of chromosome segregation during anaphase. The checkpoint monitors the completion of all the prerequisite steps before chromosome segregation to determine whether the segregation process should proceed or be delayed.
Many proteins function together to control the spindle assembly checkpoint. Mutations affecting these proteins may allow cells to proceed into anaphase prematurely, resulting in the...
3.8K
What is the Immune System?01:38

What is the Immune System?

Overview
127.8K
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
83.9K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K